Interim analysis of a real-world precision medicine platform for molecular profiling of metastatic or advanced cancers: MONDTI

BACKGROUND: High-throughput genomic profiling of tumour specimens facilitates the identification of individual actionable mutations which could be used for individualised targeted therapy. This approach is becoming increasingly more common in the clinic; however, the interpretation of results from m...

Descripción completa

Detalles Bibliográficos
Autores principales: Kieler, Markus, Unseld, Matthias, Bianconi, Daniela, Waneck, Fredrik, Mader, Robert, Wrba, Fritz, Fuereder, Thorsten, Marosi, Christine, Raderer, Markus, Staber, Philipp, Berger, Walter, Sibilia, Maria, Polterauer, Stephan, Müllauer, Leonhard, Preusser, Matthias, Zielinski, Christoph C, Prager, Gerald W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677998/
https://www.ncbi.nlm.nih.gov/pubmed/31423337
http://dx.doi.org/10.1136/esmoopen-2019-000538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677998/
https://www.ncbi.nlm.nih.gov/pubmed/31423337
http://dx.doi.org/10.1136/esmoopen-2019-000538

Ejemplares similares